User profiles for Alexandre Sepriano

Alexandre Sepriano

Leiden University Medical Center
Verified email at lumc.nl
Cited by 8443

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

…, A Kerschbaumer, IB McInnes, A Sepriano… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

…, X Baraliakos, F Van den Bosch, A Sepriano… - Annals of the …, 2017 - ard.bmj.com
To update and integrate the recommendations for ankylosing spondylitis and the recommendations
for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA…

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

S Ramiro, E Nikiphorou, A Sepriano… - Annals of the …, 2023 - ard.bmj.com
Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR
recommendations for the management of axial spondyloarthritis (axSpA). Methods …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

…, SA Bergstra, A Kerschbaumer, A Sepriano… - Annals of the …, 2023 - ard.bmj.com
Objectives To provide an update of the EULAR rheumatoid arthritis (RA) management
recommendations addressing the most recent developments in the field. Methods An international …

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid …

S Ramiro, A Sepriano, K Chatzidionysiou… - Annals of the …, 2017 - ard.bmj.com
Objectives To assess the safety of synthetic (s) and biological (b) disease-modifying
antirheumatic drugs (DMARDs) for the management of rheumatoid arthritis (RA) to inform the …

Axial spondyloarthritis

V Navarro-Compán, A Sepriano… - Annals of the …, 2021 - ard.bmj.com
Axial spondyloarthritis (axSpA) encompasses both radiographic and non-radiographic axSpA.
It is a chronic inflammatory disease with a predilection for involving the axial skeleton. The …

Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from …

…, AF Mourão, I Silva, P Laires, A Sepriano… - RMD open, 2016 - rmdopen.bmj.com
Objectives To estimate the national prevalence of rheumatic and musculoskeletal diseases (RMDs)
in the adult Portuguese population and to determine their impact on health-related …

Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR …

C Duftner, C Dejaco, A Sepriano, L Falzon… - RMD open, 2018 - rmdopen.bmj.com
Objectives To perform a systematic literature review on imaging techniques for diagnosis,
outcome prediction and disease monitoring in large vessel vasculitis (LVV) informing the …

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of …

A Sepriano, A Kerschbaumer, JS Smolen… - Annals of the …, 2020 - ard.bmj.com
Objectives To perform a systematic literature review (SLR) concerning the safety of synthetic
(s) and biological (b) disease-modifying anti rheumatic dugs (DMARDs) to inform the 2019 …

Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for …

A Kerschbaumer, A Sepriano, JS Smolen… - Annals of the …, 2020 - ard.bmj.com
Objectives To inform the 2019 update of the European League against Rheumatism (EULAR)
recommendations for the management of rheumatoid arthritis (RA). Methods A systematic …